Clinical Trials Browser

Phase 2 × Neoplasm Metastasis × amivantamab × Clear all

NCT05117931 2026-02-17

A Study of Amivantamab in People With Esophagogastric Cancer

Phase 2 Active not recruiting

Neoplasm Metastasis